Project Grant R01GM155536
- Federal Grant Award Summary The University of Washington received a $380,371 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for February 28, 2031. The grant funds the development of computational methods to infer cellular history from single-cell sequencing data, enabling disease progression analysis in tissues that cannot be accessed...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $427,625 Project Grant to the University of Washington, effective September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of capillaric microfluidics technology for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry (MS) systems. The research addresses a...
- Federal Project Grant Award Summary The University of Washington received a $2.1M Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for April 30, 2030. The grant funds development of ultrahigh multiplexing (>1000-plex) spectrally barcoded fluorescent probes and associated methods for spatial transcriptomics applications. The primary deliverable...
- Federal Project Grant Award Summary The University of Washington received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. This award funds fundamental research investigating the molecular coordination between two critical second messenger signaling pathways—cyclic diguanylate monophosphate (c-di-GMP) and cyclic adenosine...
- Federal Project Grant Award Summary The University of Washington received a $1,368,400 Project Grant awarded on June 1, 2026, by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). This four-year award, scheduled for completion on May 31, 2030, supports the development of novel analytical tools to identify proline cis/trans isomerization states in protein sequences. The project deliverable involves the creation...
- Federal Project Grant Award Summary The University of Washington received a $397,158 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. This research initiative focuses on the biosynthesis, discovery, and biocatalytic production of halogenated nucleosides and nucleoside-sulfamates—pharmaceutical compounds with demonstrated antiviral,...
- Federal Grant Award Summary The University of Washington received a $388,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026, through April 30, 2031. The award supports fundamental research addressing mechanisms and sources of interindividual variability in drug pharmacokinetics and adverse drug reactions. The research program delivers mechanistic insights into...
- Federal Project Grant Award Summary The University of Washington received a $427,625 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds research to develop a novel nano-prodrug delivery platform that targets microbiome-modulating molecules to the distal gastrointestinal tract while integrating physiologically-based...
- Federal Project Grant Award Summary The University of Washington received a $716,188 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 15, 2025, with a completion date of April 30, 2030. The research focuses on developing new catalytic transformations for alkene synthesis through investigation of organoboron compound reactivity in the presence of transition-metal catalysts. This...
- Federal Project Grant Award Summary The Washington University received a $483,175 Project Grant award effective June 1, 2026, through January 1, 2031, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds fundamental basic research to elucidate mechanosensitive mechanisms that regulate cellular transcription and cell-to-cell signaling during tissue morphogenesis and patterning. The research...
The University of Washington received a $317,439 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through January 31, 2030. The award supports the development of Smoldyn, a spatial modeling software tool designed to advance cellular biology research by enabling simultaneous simulation of proteins, filaments (including DNA and actin), and membrane dynamics—capabilities not currently available in general-purpose simulators. The project will develop and implement two primary algorithm sets within the existing Smoldyn software platform. The first focuses on filament dynamics modeling, capturing bending, twisting, branching, excluded volume effects, and interactions between filaments and molecules or surfaces to support simulation of molecular motors, DNA transcription, and protein feedback mechanisms. The second targets membrane dynamics, including deformation, endocytosis, and cell division processes. The research team, which includes members from a laboratory combining experimental and theoretical work, will apply the developed software to model actin assembly dynamics and actin-driven endocytosis, thereby validating and directing the algorithm development. Upon completion, the enhanced Smoldyn simulator will enable researchers to model a broad range of elementary cell biology processes critical to understanding transcription, cell division, endocytosis, and cell motility.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $317.4k | 4/27/26 |